Sunday, September 26

Coronavirus vaccines: Oxford-AstraZeneca will test combining its vaccine with the Russian Sputnik V

  • Drafting
  • BBC World News


It is not yet known how many people will participate in these trials.

The British company AstraZeneca announced that it will start recruiting people over 18 years of age to participate in clinical trials that will combine the vaccine it develops together with the University of Oxford with the Russian Sputnik V vaccine, produced by the Gamaleya Institute in Moscow.

The goal of combining the two vaccines is to see if that way increases immune response and improves protection against SARS-CoV-2, the virus that causes covid-19.

As the company informed the BBC, the trials will take place in Russia, but it is not yet clear when they will start or on how many people this immunization will be tested.

“Scientific collaboration with the Gamaleya Research Institute is important to explore the potential of combining vaccines to unlock synergies in protection and accessibility,” AstraZeneca noted in a press release.

Leave a Reply

Your email address will not be published. Required fields are marked *